Needham Initiates Coverage On iRadimed with Hold Rating

Benzinga Newsdesk www.benzinga.com Neutral 82.0%

Neg 0% Neu 82% Pos 0%

Needham analyst David Saxon initiates coverage on iRadimed (NASDAQ:IRMD) with a Hold rating.

Comments

No comments yet. Be the first!